Skip to content

Application of Cell Salvage in Cardiac Surgery with a High Risk of Transfusion

A Prospective Randomized and Controlled Trial of Cell Salvage in Cardiac Surgery with a High Risk of Transfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003268
Enrollment
Unknown
Registered
2013-06-09
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiopathy

Interventions

Group CS:Cell Salvage
Control:Non cell salvage

Sponsors

Zhejiang Province People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: according with two or more of the following conditions: 1. aged>70years; 2. renal dysfunction (creatinine >1.5mg/dL); 3. liver insufficiency (child B or C); 4. Body surface area <1.6 m2; 5. hemoglobin levels < 13 g/dl in males and <12 g/dl in females; 6. Platelets count <50*10^9/l or any dysfunction; 7. any coagulation disorders; 8. intake of aspirin three days prior surgery or clopidogrel seven days prior surgery; 9. reoperations; 10. multiple valve replacement, combined or without CABG.

Exclusion criteria

Exclusion criteria: emergency operation

Design outcomes

Primary

MeasureTime frame
proportion of allogeneic blood transfusion;quantity of allogeneic blood transfusio;

Secondary

MeasureTime frame
Hematology and biochemistry variables (sampled preoperatively , at the end of the CPB, at the end of the surgery and at 24 h after operation);Adverse events after surgery;The cost of allogeneic blood products;The cost of allogeneic blood products;

Countries

China

Contacts

Public ContactShe-liang SHEN
hz-ssl@163.com+86 13857194168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026